Virtual Exhibit Hall

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We discover, develop, manufacture and deliver innovative medicines to help millions of patients.

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Established Brands business.

At Astellas, we are relentless in our pursuit of scientific progress and in identifying unmet medical needs by monitoring the changes in healthcare from multiple perspectives. We are committed to the realization of greater VALUE by patients and healthcare systems around the world. We achieve this by leveraging our strengths to create innovative new drugs and to find solutions that drive patient access to healthcare and better outcomes.

Bausch + Lomb is a global eye health organization with core businesses in over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry.

CorneaGen's™ mission is to provide the highest quality donor tissue, unparalleled customer service and superior products that transform how ophthalmologists treat and care for people impacted by corneal disease. Through innovations in tissue processing technology and surgical devices, advocacy for patient access and payor reimbursement policies, CorneaGen is advancing the next generation of cornea care. Our latest innovation CTAK provides an exciting option for the treatment of keratoconus.

We develop, manufacture, & distribute innovative solutions for products, technologies, & services used by eyecare professionals for quality patient care.

We invest continually and for the long term – advancing the research, development and expertise needed to improve patients’ lives. Our robust clinical development program is evaluating potential treatments for vision-threatening eye conditions including wet age-related macular degeneration (AMD), diabetic macular edema (DME), diabetic retinopathy (DR), retinal vein occlusion (RVO), geographic atrophy (GA) and more.

Founded in 1920 by William Hadley, an educator who lost his eyesight later in life, Hadley offers practical help, connection and support free of charge to anyone with a visual impairment, their families and professionals supporting them. With Hadley, you can discover new ways to do things that have become more difficult due to vision loss and connect with a network of peers who get it." And you don't need to come to Hadley. Hadley's help comes to you; online.

Halozyme researched and developed the only Human recombinant Hyaluronidase. Hylenex is utilized primarily in Ophthalmology Eye Blocks prior to surgery.

Heidelberg Engineering continuously optimizes imaging and healthcare IT technologies to provide ophthalmic diagnostic solutions that empower clinicians to improve patient care. From its inception in 1990, the company has collaborated with scientists, clinicians and industry to develop innovative products that deliver clinically relevant benefits.

Kedrion BioPharma is a plasma-derived biotech company offering the first-in-class medication for the treatment of Ligneous Conjunctivitis.

Keenova is a purpose-driven therapeutics company that strives to help patients with rare or unaddressed conditions live happier and healthier lives. We bring deep expertise and resolve to every therapeutic area we serve, including immunology, urology, orthopedics, critical care, and pediatric endocrinology. Learn more at www.keenova.com.

Lions World Vision Institute leverages industry leading expertise, resources, and groundbreaking innovations designed to streamline cornea transplant procedures and improve clinical outcomes. Learn about our latest innovations, TransplantREADY Endo-In DMEK, DSAEK and OptiGraft CAIRS for surgical management of keratoconus.

Nextech's Ophthalmology-specific EHR improves patient care, simplifies compliance, and comes fully integrated with an intuitive, user-friendly Practice Management solution. Experience the freedom of adaptable templates and intuitive workflows that streamline operations, improve performance, and take the grunt work out of compliance. Visit www.nextech.com to learn more.

New World Medical was founded with a mission to benefit humanity. We pursue this purpose by developing and manufacturing innovative surgical devices that provide vision-preserving treatments for patients with glaucoma.

Optivate serves the ophthalmic community by providing state of the art Ophthalmology-Only EMR, PM, imaging, RCM, Axon Patient Engagement, and optical solutions.

Optos develops retinal imaging and analysis tools for ophthalmologists. Thousands of peer reviewed studies confirm that optomap® ultra-widefield imaging helps doctors more effectively detect and treat retinal pathology. optomap® is revolutionizing ophthalmic practice flow and helping doctors save sight and save lives.

Rayner is a manufacturer and developer of innovative intraocular lenses (IOLs) and associated pharmaceuticals including Omidria.

RxSight® is an ophthalmic medical technology corporation headquartered in Aliso Viejo, California that has commercialized the Light Adjustable Lens (LAL®), the world’s™ first and only adjustable intraocular lens (IOL) that is customized after cataract surgery. The company’s™ mission is to revolutionize the premium cataract surgery experience by allowing surgeons to partner with their patients to achieve optimized results for every unique eye.

ScienceBased Health (SBH) has provided evidence-based nutraceuticals for the widest array of eye conditions & practice-building programs with unparalleled support since 1997. Products include: HydroEye®, clinically tested dry eye relief (Cornea, Oct 2013); clinically tested OpticNerve Formula®; MacularProtect Complete® AREDS2 + multi; and more.

Sun Ophthalmics is reenergizing eye care. We are a US division of Sun Pharma, a global specialty pharmaceutical corporation with operations in over 150 countries. Our mission is to launch innovative ophthalmic products that complement your approach to treatment. We focus on your unmet treatment needs in patient care so you can focus on your patients. Discover a brighter future in eye care. For more information on our products and vision, visit

Topcon Healthcare is reimagining how the world sees healthcare. Healthcare from the Eye™ leverages robotic diagnostics to deliver oculomics in a connected care system, turning routine eye exams and ocular data into powerful insights that drive earlier detection, proactive care, and healthier outcomes across every setting, from primary care to eye care practices.

Viatris Inc. (NASDAQ: VTRS) is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020 through the combination of Mylan and Pfizer's Upjohn business, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories.

With a special focus on ophthalmology and ophthalmic surgery, ZEISS Medical Technology supports healthcare professionals in setting new standards of care with proven medical technology and broad application competence based on cutting-edge innovations. Our global teams have succeeded in developing innovative technologies, digital solutions, and specific applications for the workflows of our customers, which enable them to preserve vision into old age. In addition to developing cutting-edge medical products, we focus on developing and establishing solutions that enable the secure and efficient management of health data, improve workflow automation, and enable the use of intelligent algorithms such as machine learning or artificial intelligence. Our workflow solutions enable us as a medical technology company to take a holistic approach to addressing customer needs and to make a significant contribution to the digital transformation of the healthcare system. For more information visit our website at www.zeiss.com/med